Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
In one of biotech’s hottest areas and with big partners like…
Clinical
CytoDyn Announces Execution of Exclusive Agreement with American Regent for Distribution…
Commercial
Rexgenero Appoints Dr Gilbert Wagener as Senior Vice President and Chief…
Commercial
Abivax treats first patient in Phase 2b/3 ABX464 Covid-19 clinical trial
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
UK mulls joining EU coronavirus vaccines strategy – FirstWord Pharma
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
In one of biotech’s hottest areas and with big partners like…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Clinical
Gilead’s Veklury gains conditional EU approval for treatment of COVID-19 –…
Clinical
The European Commission has Granted Orphan Medicinal Product Designation in the…
Clinical
Hydroxychloroquine found to significantly cut death rates in new COVID-19 study…
Clinical
Discovery of new step in how brain cells work could lead…
Home
Therapy areas
Psychiatry
Psychiatry
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Psychiatry
Minerva MDD Treatment Fails Mid-Stage Trial, Company Has No Further Development Plans
Biospace News
-
December 19, 2019
Psychiatry
Minerva Neurosciences scraps antidepressant drug candidate MIN-117 after failed mid-stage trial
Psychiatry
Axsome’s experimental drug AXS-05 hits main goal of late-stage major depressive disorder study
Psychiatry
Acadia details positive results from late-stage study of pimavanserin for dementia-related psychosis
Psychiatry
ACADIA Pharmaceuticals Announces Positive Top-line Results from ADVANCE Trial of Pimavanserin as Treatment for Negative Symptoms of Schizophrenia
Psychiatry
Research Roundup: New Test for Autism and More
Biospace News
-
July 12, 2019
0
Psychiatry
Alkermes to Present New Data From Mental Health Portfolio at the...
Biospace News
-
May 22, 2019
0
Psychiatry
Neurocrine Biosciences to Present New Quality-of-Life Data Analysis from RE-KINECT, the...
Firstwordpharma News
-
May 16, 2019
0
Psychiatry
Once-Daily Trazodone as Effective as Venlafaxine XR for Major Depressive Disorder:...
Firstwordpharma News
-
April 10, 2019
0
Psychiatry
Achieve Life Sciences Announces Successful Completion of the Second and Final...
Biospace News
-
April 2, 2019
0
1
2
3
4
Page 1 of 4
- Advertisement -
MOST POPULAR
QED and Parent Company BridgeBio Announce Preclinical Data Supporting Tolerability and...
October 17, 2019
Axovant Launches Arvelle Therapeutics to Commercialize Epilepsy Drug
February 14, 2019
Alexion Reports First Quarter 2019 Results
April 25, 2019
Milestone Pharmaceuticals Appoints Paul Edick Chairman of its Board of Directors
April 16, 2019
Load more
HOT NEWS
Others
Over 16 mn children receive polio vaccine under Egyptian government campaign:...
Others
Enterin’s DEMET Study Enrolls First Patient With Parkinson’s Disease Dementia (PDD)
Deals
Impel NeuroPharma Closes $67.5 Million Series D to Advance CNS Portfolio
Others
Pi Therapeutics Announces $19.7 Million Series B Financing
